$NKTR Presents Clinical Data for Performance of NKTR-214 in Metastatic Urothelial Carcinoma Patients

Clinical Data Presented from PIVOT-02 Study of Bempegaldesleukin (NKTR-214) with Nivolumab in Metastatic Urothelial Carcinoma Patients at the 2019 ASCO Genitourinary Cancers Symposium Analyst conference call with urothelial cancer specialist to be held  at 2:00 p.m. Pacific Time today SAN FRANCISCO, February 15, 2019 — Nektar Therapeutics (Nasdaq: NKTR) announced today a presentation of new clinical data […]